Clinical Trials on Rectal Metastatic Cancer in Italy

Total 5070 results

Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Radiometabolic Therapy With 177Lu PSMA in PSMA PET/CT Positive Advanced/Metastatic Tumours: (LUBASKET)

Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy ((GreenEye-CRC))

Rectal Cancer | Lymph Node Cancer Metastatic

Italy
National Cancer Institute, Naples

Recruiting

Multicenter Cohort Prospective Study on Multidisciplinary Treatment of Rectal Cancer (CROSS-1)

Metastatic Colorectal Cancer

Italy
IRCCS San Raffaele

Recruiting

Liver Embolization Approaches for Tumor Management (LEATUM)

Hepatocellular Carcinoma | Metastatic Cancer | Primary Liver Cancer | Cholangiocarcinoma | Metastatic Gastric Cancer | Metastatic Pancreatic Cancer | Metastatic Colon Cancer

Italy
Niguarda Hospital

Withdrawn

AIMS Academy Clinical Research Network - Non Metastatic Rectal Cancer Operated on With Curative Intent (FUCORE)

Non Metastatic Rectal Cancer

Italy
Rottapharm Biotech
Agenus Inc.

Active, not recruiting

A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients

Solid Tumor | Metastatic Microsatellite-stable Colorectal Cancer | Mismatch Repair Protein Proficient | Refractory Metastatic Colorectal Cancer

Italy
Istituto Clinico Humanitas

Active, not recruiting

High Dose SBRT for Abdominal-Pelvic Lymph Nodal Lesions in Oligometastatic Patients

Lymph Node Cancer Metastatic

Italy
National Cancer Institute, Naples

Active, not recruiting

MAnagement of METastatic Disease In Campania (MAMETIC) (MAMETIC)

Metastatic Disease

Italy
Daiichi Sankyo
AstraZeneca

Recruiting

A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)

Metastatic Cancer | Advanced Cancer

Spain, Korea, Republic of, Belgium, Italy, France, United States, Australia, Japan, Taiwan, United Kingdom
Gruppo Oncologico del Nord-Ovest

Active, not recruiting

AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients (AVETRIC)

Metastatic Colorectal Cancer

Italy
Azienda Ospedaliero, Universitaria Pisana

Unknown

Evaluation of VEGF Polymorphism as Predictive Factor in Metastatic Colorectal Cancer Treated With Folfiri Plus Bevacizumab (PROVETTA)

Metastatic Colorectal Cancer

Italy
European Organisation for Research and Treatment...

Terminated

Adjuvant Radiation Therapy in Treating Patients With Brain Metastases

Metastatic Cancer

France, Finland, United Kingdom, Belgium, Israel, Germany, Switzerland, Netherlands, Turkey, Italy, Portugal, Spain, Latvia
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer

Italy
National Cancer Institute, Naples

Recruiting

Aflibercept or Bevacizumab as Second-line Treatment of RAS Mutated Metastatic Colorectal Cancer (ARBITRATION)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Recruiting

Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients (HAITI)

Colorectal Cancer Metastatic

Italy
Azienda Ospedaliero, Universitaria Pisana

Completed

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

Italy
University of Padova
Istituto Oncologico Veneto IRCCS; Azienda Ulss 2 Marca Trevigiana; Associazione... and other collaborators

Recruiting

IMMUNOlogical Microenvironment in REctal Adenocarcinoma Treatment (IMMUNOREACT1)

Rectal Cancer Stage T1-T2 | Rectal Cancer Nodal Metastasis

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer (MAYA)

Metastatic Colorectal Cancer

Italy
University of Rome Tor Vergata

Completed

Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer

Italy
Istituto Oncologico Veneto IRCCS

Active, not recruiting

First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer (COBRA)

Elderly Metastatic Colorectal Cancer Patients

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients (CAPTEM)

Metastatic Colorectal Cancer

Italy
Istituto Oncologico Veneto IRCCS
Roche Pharma AG

Active, not recruiting

The GOLD Study: G8 in OLDer Patients (GOLD)

Elderly Metastatic Colorectal Cancer Patients

Italy
Ospedale San Carlo Borromeo

Active, not recruiting

Panitumumab Skin Toxicity Prevention Trial (PaSTo)

Colorectal Cancer Metastatic | Skin Toxicity

Italy
Gruppo Oncologico del Nord-Ovest
Roche Pharma AG

Completed

FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients (AtezoTRIBE)

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Panitumumab-based Maintenance in Patients With RAS Wild-type, Metastatic Colorectal Cancer (Valentino) (Valentino)

Metastatic Colorectal Cancer

Italy
Sanofi
Regeneron Pharmaceuticals

Terminated

Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient (AMOR)

Colorectal Cancer Metastatic

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Study of I Line FOLFOX + Panitumumab vs 5FU + Panitumumab in RAS and BRAF WT Metastatic Colorectal Cancer Elderly Patients (PANDA)

Elderly Metastatic Colorectal Cancer Patients

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib. (RESCUE)

Metastatic Colorectal Cancer

Italy
Istituto Scientifico Romagnolo per lo Studio e...

Completed

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

Colorectal Cancer Metastatic

Italy
Fondazione Policlinico Universitario Agostino Gemelli...
Baxter Healthcare Corporation

Unknown

Efficacy and Tolerability of Hemopatch After Hepatic Resection

Hepatectomy | Hemostasis | Cancer, Metastatic

Italy
National Cancer Institute, Naples

Recruiting

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients With LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells) (PRELUDE-1)

Colorectal Cancer Metastatic

Italy
National Cancer Institute, Naples

Recruiting

Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer (REVOLUTION)

Ras-mutated Metastatic Colorectal Cancer

Italy
University of Campania "Luigi Vanvitelli"

Completed

Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer

Metastatic Colorectal Cancer | RAS Wild Type

Italy
Azienda Ospedaliera di Padova

Unknown

Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma

Neoplasm Metastasis | Cholangiocarcinoma | Metastatic Liver Cancer

Italy
Istituto Oncologico Veneto IRCCS
Azienda Ospedaliera di Padova; Azienda ULSS 16 Padova

Completed

Immunophenotyping of Metastases From Colorectal Cancer

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Completed

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS (TRIPLETE)

Metastatic Colorectal Cancer

Italy
Fondazione del Piemonte per l'Oncologia

Unknown

Genotyping of Metastatic Colorectal Cancer Patients for Precision Medicine Clinical Trials (FUNNEL)

Metastatic Colorectal Cancer

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy (DIAMOND)

Metastatic Breast Cancer

Italy
Istituto Ortopedico Galeazzi

Completed

Investigation of Cancer Cell Extravasation Through mRNA Analysis of Organ-specific Endothelial Cells and Microfluidics

Breast Cancer Metastatic

Italy
Consorzio Oncotech
Clinical Research Technology S.r.l.

Unknown

Observation of Medical Treatments in MBC HER2-negative Patients (AMBRA)

Metastatic Breast Cancer

Italy
Armando Santoro, MD

Completed

Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects

Colorectal Cancer Metastatic | C-met Overexpression

Italy
Fondazione del Piemonte per l'Oncologia

Recruiting

Early Detection of Relapses in Stage IV Colorectal Cancer Patients (REDCLOUD)

Metastatic Colorectal Cancer

Italy
Gruppo Oncologico del Nord-Ovest

Unknown

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC (TRIBE2)

Metastatic Colorectal Cancer

Italy
Azienda Ospedaliero, Universitaria Pisana

Completed

Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer (CIRCUS)

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Istituto Di Ricerche Farmacologiche Mario Negri; Gruppo Oncologico del Nord-Ovest

Recruiting

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation (COLT)

Neoplasms | Colorectal Cancer Metastatic | Liver Metastases | Liver Neoplasm

Italy
Bayer

Active, not recruiting

A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment (RegoSeq)

Metastatic Colorectal Cancer

Spain, Italy, France
Gruppo Oncologico del Nord-Ovest

Recruiting

Trifluridine/Tipiracil in Combination With Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients. (TriComB)

Colorectal Cancer Metastatic

Italy
Gruppo Oncologico del Nord-Ovest

Completed

FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer (TRIP)

Metastatic Colo-rectal Cancer

Italy
University of Chicago
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale...

Completed

A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients

Metastatic Colorectal Cancer

United States, Italy
EMD Serono

Terminated

MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)

Metastatic Colorectal Cancer

Italy, Spain, Belgium

Clinical Trials on Rectal Metastatic Cancer in Italy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations